Prognostic Biomarkers for Malignant Pleural Mesothelioma Treated with Chemotherapy

被引:0
|
作者
Akgun, Hakan [1 ]
Metintas, Selma [2 ]
Ak, Guntulu [3 ]
Demirkol, Secil [4 ]
Aydin, Resat [5 ]
Isbilen, Murat [4 ]
Gure, Ali [4 ]
Metintas, Muzaffer [3 ]
机构
[1] Eskisehir Osmangazi Univ, Fac Med, Dept Chest Dis, Eskisehir, Turkey
[2] Eskisehir Osmangazi Univ, Fac Med, Dept Publ Hlth, Lung & Pleural Canc Res & Clin Ctr, Eskisehir, Turkey
[3] Eskisehir Osmangazi Univ, Fac Med, Dept Chest Dis, Lung & Pleural Canc Res & Clin Ctr, Eskisehir, Turkey
[4] Ihsan Dogramaci Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey
[5] Eskisehir Osmangazi Univ, Dept Publ Hlth, Fac Med, Eskisehir, Turkey
关键词
Prognosis; Gene Expression; Mesothelioma;
D O I
10.1016/j.jtho.2016.11.1938
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.03-039
引用
收藏
页码:S1369 / S1369
页数:1
相关论文
共 50 条
  • [1] PROGNOSTIC BIOMARKERS IN MALIGNANT PLEURAL MESOTHELIOMA
    Mezzapelle, R.
    Miglio, U.
    Rena, O.
    Mercalli, F.
    Veggiani, C.
    Paganotti, A.
    Buosi, R.
    Rinaldi, M.
    Boldorini, R.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [2] Biomarkers and prognostic factors for malignant pleural mesothelioma
    Vigneri, Paolo
    Martorana, Federica
    Manzella, Livia
    Stella, Stefania
    [J]. FUTURE ONCOLOGY, 2015, 11 (24) : 29 - 33
  • [3] Inflammatory Biomarkers as Prognostic Factors for Malignant Pleural Mesothelioma
    Yerigeri, K.
    Morrow, B.
    Steinberg, S. M.
    Sengupta, M.
    Hassan, R.
    Puthiamadathil, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S388 - S388
  • [4] Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma
    Liu, Hui
    Wu, Licun
    Ji, Kai
    Wang, Wei
    [J]. TUMOR BIOLOGY, 2015, 36 (10) : 7375 - 7384
  • [5] Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
    Strbac, Danijela
    Goricar, Katja
    Dolzan, Vita
    Kovac, Viljem
    [J]. DISEASE MARKERS, 2017, 2017
  • [6] A critical update on prognostic and predictive biomarkers in malignant pleural mesothelioma
    Ghanim B.
    Hoda M.A.
    Klikovits T.
    Dome B.
    Grusch M.
    Filipits M.
    Klepetko W.
    Berger W.
    Hegedus B.
    [J]. memo - Magazine of European Medical Oncology, 2015, 8 (1) : 52 - 56
  • [7] Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma
    Hashimoto, Masaki
    Takeuchi, Jiro
    Takuwa, Teruhisa
    Kuroda, Ayumi
    Nakamura, Akifumi
    Nakamichi, Toru
    Matsumoto, Seiji
    Kondo, Nobuyuki
    Nakano, Takashi
    Morimoto, Takeshi
    Hasegawa, Seiki
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (01): : 404 - 413
  • [8] Chemotherapy for malignant pleural mesothelioma
    Vogelzang, Nicholas J.
    [J]. LANCET, 2008, 371 (9625): : 1640 - 1642
  • [9] Chemotherapy for Malignant Pleural Mesothelioma
    Garland, Linda L.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2011, 12 (02) : 181 - 188
  • [10] Chemotherapy for malignant pleural mesothelioma
    Tomek, S
    Manegold, C
    [J]. CURRENT OPINION IN ONCOLOGY, 2003, 15 (02) : 148 - 156